MD | DC | VA
Our Goal: To become a Top 3 BioHealth Hub by 2023.
Driving Innovation and Entrepreneurship
- World–renowned research institutions and universities
- Influential policymakers and advocacy groups pioneering new health strategies
- World–leading infectious disease research and vaccine development
- Fastest growing region for healthcare companies in the U.S.
- Rated #1 in the nation for science and engineering talent
- Mission control for the National Cancer Moonshot Initiative
Founding Partners
Gaithersburg, MD—April 18, 2019 – Viela Bio today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for the Company’s anti-CD19 monoclonal antibody inebilizumab, an…
ROCKVILLE, Md., April 17, 2019 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®Technology Platform,…
Emma Walmsley, the CEO of GlaxoSmithKline, discussed the pharmaceutical industry and the role of leadership at the Stanford Medicine Dean’s Lecture on Tuesday. GlaxoSmithKline, commonly known as GSK, is a…
GAITHERSBURG, Md., April 16, 2019 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced results from the interim analysis of its Phase 2 clinical study evaluating the safety and immunogenicity of the company’s chikungunya…
Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare, positioning Catalent for accelerated long-term growth SOMERSET, N.J. and BALTIMORE, M.D. – April 15, 2019 – Catalent,…
Carrie Roth is president and CEO of the Virginia Bio+Tech Park and of Activation Capital. The park’s board is seeking a new president and CEO and Roth would stay as…